跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46,425 条关于
“Rigel Pharmaceuticals Inc.”
全部
46,425
临床试验
11,588
药物
3,164
机构
7,497
资讯
24,176
去年
TAVALISSE® (Fostamatinib) Approved in Mexico for Chronic ITP Treatment
去年
New Clinical Trials Report Maps Global Landscape for Autoimmune Hemolytic Anemia Research
2个月前
Rigel Pharmaceuticals Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer to Drive Oncology Pipeline
去年
Rigel Pharmaceuticals Unveils Promising Final Data from GAVRETO and REZLIDHIA Clinical Trials at ASCO and EHA 2025
去年
Sickle Cell Disease Pipeline Shows Robust Growth with 60+ Therapies in Development Across Multiple Clinical Phases
11个月前
Rigel Pharmaceuticals Reports Strong Growth Across Oncology Portfolio with 44% Revenue Increase
去年
Rigel Pharmaceuticals Reports Strong Growth with TAVALISSE and REZLIDHIA in 2024, Expands Global Reach
2年前
Rigel Pharmaceuticals Initiates Phase Ib/II Trial of REZLIDHIA Combination Therapy for mIDH1 AML
11个月前
Rigel Pharmaceuticals Advances R289 Phase 1b Trial for Lower-Risk MDS with First Dose Expansion Patient
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
第 1 页，共 2418 页
上一页
下一页
